-transparent.png){kind=logo}
The therapeutic efficacy of propranolol in four and two daily doses was compared in 63 treated hypertensive patients in a multicentre trial. After 3 months of a stable diastolic blood pressure while receiving propranolol four times a day the patients were switched to a twice-a-day regimen, the drug being given at 8 am and 8 pm, with the same total daily dose, for 3 more months. Blood pressures and heart rates were measured at 8 am, 12 noon, 4 pm and 8 pm at 4-week intervals. There were no significant changes in mean blood pressure after the change to the twice-a-day regimen, although some patients reported new side effects. Compliance appeared to be unaffected.
Related Publications
S M MacLeod, and
P Hamet, and
H Kaplan, and
P Larochelle, and
J Nadeau, and
R I Ogilvie, and
R E Rangno, and
J Ruedy, and
E M Sellers, and
T Y Ti
December 1973,
Acta medica Scandinavica,
S M MacLeod, and
P Hamet, and
H Kaplan, and
P Larochelle, and
J Nadeau, and
R I Ogilvie, and
R E Rangno, and
J Ruedy, and
E M Sellers, and
T Y Ti
September 1971,
Lancet (London, England),
S M MacLeod, and
P Hamet, and
H Kaplan, and
P Larochelle, and
J Nadeau, and
R I Ogilvie, and
R E Rangno, and
J Ruedy, and
E M Sellers, and
T Y Ti
January 1979,
The Journal of international medical research,
S M MacLeod, and
P Hamet, and
H Kaplan, and
P Larochelle, and
J Nadeau, and
R I Ogilvie, and
R E Rangno, and
J Ruedy, and
E M Sellers, and
T Y Ti
January 1981,
Annals of clinical research,
S M MacLeod, and
P Hamet, and
H Kaplan, and
P Larochelle, and
J Nadeau, and
R I Ogilvie, and
R E Rangno, and
J Ruedy, and
E M Sellers, and
T Y Ti
March 1976,
Clinical pharmacology and therapeutics,
S M MacLeod, and
P Hamet, and
H Kaplan, and
P Larochelle, and
J Nadeau, and
R I Ogilvie, and
R E Rangno, and
J Ruedy, and
E M Sellers, and
T Y Ti
January 1981,
Journal of clinical pharmacology,
S M MacLeod, and
P Hamet, and
H Kaplan, and
P Larochelle, and
J Nadeau, and
R I Ogilvie, and
R E Rangno, and
J Ruedy, and
E M Sellers, and
T Y Ti
September 1982,
Clinical pharmacology and therapeutics,
S M MacLeod, and
P Hamet, and
H Kaplan, and
P Larochelle, and
J Nadeau, and
R I Ogilvie, and
R E Rangno, and
J Ruedy, and
E M Sellers, and
T Y Ti
January 1998,
Cancer chemotherapy and pharmacology,
S M MacLeod, and
P Hamet, and
H Kaplan, and
P Larochelle, and
J Nadeau, and
R I Ogilvie, and
R E Rangno, and
J Ruedy, and
E M Sellers, and
T Y Ti
December 1988,
Journal of human hypertension,
S M MacLeod, and
P Hamet, and
H Kaplan, and
P Larochelle, and
J Nadeau, and
R I Ogilvie, and
R E Rangno, and
J Ruedy, and
E M Sellers, and
T Y Ti
January 1982,
Clinical pharmacy,
